tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Orchard Therapeutics PLC's activity chart (see below) currently has 7 price targets and 9 ratings on display.
Analysts average stock forecasts to be materialized ratio is 40.63% with an average time for these price targets to be met of 110.5 days.
Most recent stock forecast was given by DAE GON HA from STIFEL on 05-Oct-2023. First documented stock forecast 26-Nov-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Oct-2023
$16
$-0.7 (-4.19%)
$22
2 years 9 months 4 days ago
(05-Oct-2023)
1/2 (50%)
$0.05 (0.31%)
1
Buy Since 14-Sep-2020
2 years 11 months ago
(09-Aug-2023)
0/2 (0%)
$88 (107.32%)
Buy Since 29-Dec-2021
$15
$-1.7 (-10.18%)
$15
3 years 12 days ago
(27-Jun-2023)
3/3 (100%)
$9.77 (186.81%)
107
Buy Since 13-Mar-2023
$5
$-11.7 (-70.06%)
3 years 3 months 26 days ago
(13-Mar-2023)
1/1 (100%)
$0.05 (1.01%)
1
Buy Since 05-Sep-2019
$13
4 years 1 months 26 days ago
(13-May-2022)
2/2 (100%)
$-34.2 (-72.46%)
621
What is ORTX (Orchard Therapeutics PLC) average time for price targets to be met?
Which analyst has the current highest performing score on ORTX (Orchard Therapeutics PLC) with a proven track record?
Which analyst has the most public recommendations on ORTX (Orchard Therapeutics PLC)?
Which analyst is the currently most bullish on ORTX (Orchard Therapeutics PLC)?
Which analyst is the currently most reserved on ORTX (Orchard Therapeutics PLC)?
